Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
New hope for kids with arthritis: drug trial launches
Disease control Recruiting nowThis study tests a drug called bimekizumab in children aged 2 to 17 with certain types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). The goal is to see how the drug moves through the body and if it is safe. About 40 children will receive t…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new medicine called galvokimig in 160 adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see if different doses can reduce skin redness, itching, and rash better than a placebo. Participants will receive either the drug or a placebo for 1…
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New drug hope for muscle weakness condition in chinese patients
Disease control Recruiting nowThis study tests a drug called rozanolixizumab in 40 Chinese adults with generalized myasthenia gravis, a condition causing muscle weakness. The main goal is to see if the drug improves daily activities like walking and talking over 43 days. Participants must have certain antibod…
Phase: PHASE4 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New drug UCB5285 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis study is an early test of a new drug, UCB5285, in healthy volunteers. The main goal is to see if single doses are safe and how the body processes the drug. About 96 healthy adults, including some of Japanese descent, will take part. This study does not aim to treat any disea…
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:49 UTC